111 Shares Outstanding 2018-2025 | YI

111 shares outstanding from 2018 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
111 Annual Shares Outstanding
(Millions of Shares)
2024 9
2023 8
2022 8
2021 8
2020 8
2019 8
2018 5
2017 4
111 Quarterly Shares Outstanding
(Millions of Shares)
2025-06-30 9
2025-03-31 9
2024-12-31 9
2024-09-30 9
2024-06-30 9
2024-03-31 9
2023-12-31 8
2023-09-30 8
2023-06-30 8
2023-03-31 8
2022-12-31 8
2022-09-30 8
2022-06-30 8
2022-03-31 8
2021-12-31 8
2021-09-30 8
2021-06-30 8
2021-03-31 8
2020-12-31 8
2020-09-30 8
2020-06-30 8
2020-03-31 8
2019-12-31 8
2019-09-30 8
2019-06-30 8
2019-03-31 8
2018-09-30 5
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.036B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.330B 58.97
Tempus AI (TEM) United States $12.432B 0.00
Doximity (DOCS) United States $10.168B 42.08
Hims & Hers Health (HIMS) United States $9.340B 75.98
IRhythm Technologies (IRTC) United States $5.625B 0.00
Hinge Health (HNGE) United States $3.490B 0.00
Privia Health (PRVA) United States $2.882B 180.23
Heartflow (HTFL) United States $2.715B 0.00
Inspire Medical Systems (INSP) United States $2.377B 39.32
10x Genomics (TXG) United States $1.898B 0.00
Enovis (ENOV) United States $1.605B 8.43
Omnicell (OMCL) United States $1.601B 32.73
Clover Health Investments (CLOV) United States $1.368B 0.00
Azenta (AZTA) United States $1.346B 58.74
Phreesia (PHR) United States $1.319B 0.00
Schrodinger (SDGR) United States $1.309B 0.00
Claritev (CTEV) United States $1.141B 0.00
Fulgent Genetics (FLGT) United States $0.807B 0.00
Evolent Health (EVH) United States $0.583B 0.00
Talkspace (TALK) United States $0.565B 113.67
Butterfly Network (BFLY) United States $0.563B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Standard BioTools (LAB) United States $0.435B 0.00
Zepp Health (ZEPP) Netherlands $0.396B 0.00
Carlsmed (CARL) United States $0.363B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.295B 0.00
TruBridge (TBRG) United States $0.292B 13.39
CapsoVision (CV) United States $0.221B 0.00
Outset Medical (OM) United States $0.214B 0.00
MDxHealth SA (MDXH) Belgium $0.212B 0.00
Health Catalyst (HCAT) United States $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.180B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.179B 0.00
Nyxoah SA (NYXH) Belgium $0.167B 0.00
CareCloud (CCLD) United States $0.147B 8.06
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
Pulmonx (LUNG) United States $0.078B 0.00
NetraMark Holdings (AINMF) Canada $0.075B 0.00
American Well (AMWL) United States $0.068B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Evaxion - (EVAX) Denmark $0.040B 0.00
Precipio (PRPO) United States $0.032B 0.00
Predictive Oncology (POAI) United States $0.026B 0.00
Lunai Bioworks (LNAI) United States $0.022B 0.00
Zhongchao (ZCMD) China $0.018B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00